Back to newsroom
News
Stand Up To Cancer and Pancreatic Cancer North America: Our Commitment To Pancreatic Cancer Vaccine Research

June 1, 2023

Victoria Izzio-Meloche

Image of RASONQUE (daraxonrasib) bottle and carton packaging.

Stand Up To Cancer and Pancreatic Cancer North America: Our Commitment To Pancreatic Cancer Vaccine Research

Thursday, June 1, 2023Today marks a significant milestone in our continued efforts to meaningfully change pancreatic cancer outcomes. Pancreatic Cancer Canada, as part ofPancreatic Cancer North America, is proud to announce our $1.5 million commitment toStand Up To Cancer, in support of the mRNA pancreatic cancer vaccine study.

Be part of the force driving answers for this devastating disease.

Make a donation towards pancreatic cancer research and support programs.

donate today

Keep in the loop:

Read more PCNA News:

discover more

Research
Six Months is a Start

Research
We Asked. You Shared. Here’s What We Do Next.

August 19, 2026

Research
It's Probably Just Menopause...